Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Van Brandt

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Journal of Medicinal Chemistry|December 17, 2021
Modulating physicochemical properties of tetrahydropyridine-2-amine BACE1 inhibitors with electron-withdrawing groups: A systematic studyFrederik J R Rombouts, Chien-Chi Hsiao, Solène Bache, et al.
ACS Medicinal Chemistry Letters|January 21, 2022
A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In VivoAldo Peschiulli, Daniel Oehlrich, Michiel Van Gool, et al.
Journal of Medicinal Chemistry|June 2, 2012
Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulatorsFrancois Bischoff, Didier Berthelot, Michel De Cleyn, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2013
Design and synthesis of bicyclic heterocycles as potent γ-secretase modulatorsDaniel Oehlrich, Frederik J R Rombouts, Didier Berthelot, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2019
Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulatorsFrançois P Bischoff, Adriana Ingrid Velter, Garrett Minne, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Anilinotriazoles as potent gamma secretase modulatorsAdriana I Velter, François P Bischoff, Didier Berthelot, et al.
Journal of Medicinal Chemistry|February 17, 2025
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.
ACS Medicinal Chemistry Letters|August 16, 2019
Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine WarheadsDaniel Oehlrich, Aldo Peschiulli, Gary Tresadern, et al.
Plos Pathogens|May 5, 2026
An orthoflavivirus inhibitor targeting multifunctional NS2A protein, a previously unidentified targetDoortje Borrenberghs, Kitti Wing Ki Chan, Sven Van Brandt, et al.
European Journal of Medicinal Chemistry|June 1, 2005
Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitorsPatrick Angibaud, Janine Arts, Kristof Van Emelen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Medicinal Chemistry|December 17, 2021
Modulating physicochemical properties of tetrahydropyridine-2-amine BACE1 inhibitors with electron-withdrawing groups: A systematic studyFrederik J R Rombouts, Chien-Chi Hsiao, Solène Bache, et al.
ACS Medicinal Chemistry Letters|January 21, 2022
A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In VivoAldo Peschiulli, Daniel Oehlrich, Michiel Van Gool, et al.
Journal of Medicinal Chemistry|June 2, 2012
Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulatorsFrancois Bischoff, Didier Berthelot, Michel De Cleyn, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2013
Design and synthesis of bicyclic heterocycles as potent γ-secretase modulatorsDaniel Oehlrich, Frederik J R Rombouts, Didier Berthelot, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2019
Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulatorsFrançois P Bischoff, Adriana Ingrid Velter, Garrett Minne, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Anilinotriazoles as potent gamma secretase modulatorsAdriana I Velter, François P Bischoff, Didier Berthelot, et al.
Journal of Medicinal Chemistry|February 17, 2025
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.
ACS Medicinal Chemistry Letters|August 16, 2019
Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine WarheadsDaniel Oehlrich, Aldo Peschiulli, Gary Tresadern, et al.
Plos Pathogens|May 5, 2026
An orthoflavivirus inhibitor targeting multifunctional NS2A protein, a previously unidentified targetDoortje Borrenberghs, Kitti Wing Ki Chan, Sven Van Brandt, et al.
European Journal of Medicinal Chemistry|June 1, 2005
Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitorsPatrick Angibaud, Janine Arts, Kristof Van Emelen, et al.
Pageof 2